pharmaceutical investing Opiant Pharmaceuticals Announces Contract with Biomedical Advanced Research and Development Authority for Up to $4.6 Million to Accelerate Development of OPNT003
pharmaceutical investing Summit Awarded Additional $12 Million by BARDA for Phase 3 Development Programme of Ridinilazole for the Treatment of C. difficile Infection
Allied Critical Metals Closes First Tranche of Oversubscribed Non-Brokered Private Placement and Upsize to $5m of the Offering
Harvest Gold Kicks Off Drilling at Mosseau, Launches Urban-Barry Till Program, and Completes Labelle Mag Survey